116 related articles for article (PubMed ID: 95808)
1. Comparison of the cytotoxic activities of different human lymphoid tissues.
Durántez A; de Landazuri MO; Silva A; Alvarez J; Kreisler M
J Clin Lab Immunol; 1979 Apr; 2(1):59-65. PubMed ID: 95808
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activities of normal cultured human T cells.
Alvarez JM; de Landazuri MO; Bonnard GD; Herberman RB
J Immunol; 1978 Oct; 121(4):1270-5. PubMed ID: 308961
[TBL] [Abstract][Full Text] [Related]
4. Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity.
Lang NP; Ortaldo JR; Bonnard GD; Herberman RB
J Natl Cancer Inst; 1982 Aug; 69(2):339-43. PubMed ID: 6180205
[TBL] [Abstract][Full Text] [Related]
5. Natural killer activity of human lymphocytes against colon cancer cells.
Helms RA; Bull DM
Gastroenterology; 1980 Apr; 78(4):738-44. PubMed ID: 7353760
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
7. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
Dato ME; Kim YB
J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
[TBL] [Abstract][Full Text] [Related]
8. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
Santoni A; Herberman RB; Holden HT
J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
[TBL] [Abstract][Full Text] [Related]
9. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
Saxena RK; Saxena QB; Adler WH
Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
[TBL] [Abstract][Full Text] [Related]
10. Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations.
de Landazuri MO; Silva A; Alvarez J; Herberman RB
J Immunol; 1979 Jul; 123(1):252-8. PubMed ID: 376742
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
Nair MP; Schwartz SA
J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
[TBL] [Abstract][Full Text] [Related]
15. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
Sharland A; Lee JH; Saidman S; Waneck GL
Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity within the population of NK and K cells.
Jensen PJ; Koren HS
J Immunol; 1980 Jan; 124(1):395-8. PubMed ID: 6985645
[TBL] [Abstract][Full Text] [Related]
17. Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activities.
Abrams SI; Brahmi Z
J Immunol; 1988 Mar; 140(6):2090-5. PubMed ID: 3279127
[TBL] [Abstract][Full Text] [Related]
18. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
[TBL] [Abstract][Full Text] [Related]
19. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells.
Cifone MG; Festuccia C; Cironi L; Cavallo G; Chessa MA; Pensa V; Tubaro E; Santoni A
Cell Immunol; 1994 Aug; 157(1):181-94. PubMed ID: 7518750
[TBL] [Abstract][Full Text] [Related]
20. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
